Prolocor

Recent Finacing

Convertible

Recent Raise

$1.7M

Prolocor develops a precision diagnostic (pFCG) quantifying platelet FcγRIIa to stratify thrombotic risk and guide antithrombotic therapy intensity, conducting CLIA lab validation and an 800‑patient prospective cohort study.

Founded 2020

Pennsylvania, United States

1-10

Private

prolocor.com

Highlights

Focus Areas

Biotechnology

Health Care

Health Diagnostics

Medical

Recent Investors

Financials

$6.9M

Total Raised

2

Funding rounds

3

Investors

Team

Upgrade to view the team

See the team members at Prolocor.